造影デジタルマンモグラフィ（CEDM）の2030年までの市場予測： 画像タイプ、技術、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、造影デジタルマンモグラフィ（CEDM）の世界市場は2024年に4億6,259万米ドルを占め、予測期間中のCAGRは12.8％で成長し、2030年には9億5,291万米ドルに達する見込みです。

造影デジタルマンモグラフィ（CEDM）は、乳がんのスクリーニングや診断に用いられる高度な画像技術です。造影剤を患者の血流に注入し、乳房病変の異常血管を強調します。これにより、特に従来のマンモグラフィでは結論が出ないような場合に、マンモグラフィで疑わしい部分の視認性が高まります。CEDMは、デジタルマンモグラフィの利点と造影剤強調画像の利点を組み合わせたもので、特に乳腺組織が密集している場合の乳がん検出感度を向上させる。

米国の乳がん統計によると、米国では女性の約8人に1人（約12.4％）が生涯のうちに浸潤性乳がんを発症するとされています。世界保健機関（WHO）によると、乳がんはアジアにおける女性がんの約35％を占め、女性の間で最も頻度の高いがんです。

時間効率の良いプロセス

デジタルマンモグラフィは、その迅速な結果で有名で、医師がすぐに確認することができます。従来のプロセスのように、フィルムの現像に時間をかける必要はありません。検査中、技師はコンピューター画面で結果を見ることができます。特定の場所を拡大したり、集中的に観察したりすることも可能です。また、正常な乳房組織と病気の乳房組織を区別するためにコントラストを変更することも可能です。その結果、これが市場拡大の主な要因となっています。

空間分解能の低下

デジタルマンモグラフィには、空間分解能を下げる機能もあります。投影された石灰化画像は、デジタル幾何学的拡大によって最低解像度の限界を超えて上昇します。モニター上の画像拡大力が、より焦点の合った真の幾何学的拡大の代用にならないことも問題です。結果として、このことが市場の拡大を妨げています。

新技術の登場

乳がんによる死亡率は、CEDMの技術的発展や意識向上のためのいくつかの政府キャンペーンの結果、減少すると予測されています。しかし、厚い乳房では、造影デジタルマンモグラフィの導入によりがん診断が強化されます。世界の乳がん検診プログラムのイントロダクションと乳がん罹患率の上昇が市場の拡大を後押ししています。

高コスト

デジタルマンモグラフィーの価格は、従来のフィルムを使用したものより高いです。設備が改善された分、撮影時間の短縮でこのコストをカバーできると思われます。しかし、調査では乳がん発見の利点を実証するには至っていないです。さらに、従来のマンモグラフィに比べ、造影剤によるアレルギー反応の可能性が低く、放射線量も高いです。乳房MRは患者にとってより時間がかかり、高価で、不快であるため、造影マンモグラフィ・ソリューションは市場の成長を妨げています。

COVID-19の影響：

市場はCOVID-19の大流行によって悪影響を受けた。世界の大流行により、乳がん検診、がん管理訪問、がん手術が大幅に減少しました。数カ国における封鎖措置や、マンモグラフィシステムを含む多種多様なX線画像診断装置の製造・生産の遅れにより、パンデミックの流行はマンモグラフィシステム事業の成長に影響を及ぼしています。

予測期間中、診断分野が最大となる見込み

造影デジタルマンモグラフィ（CEDM）市場における診断分野は、画像技術の進歩や乳がんの早期発見が重視されるようになったことで顕著な成長を遂げています。CEDMは、従来のマンモグラフィに比べてコントラストが強化され、病変検出能力が向上しているため、診断手技における採用が進んでいます。また、早期診断の重要性や、より正確な画像診断モダリティの必要性に対する認識が高まっていることも、CEDMシステムの需要に拍車をかけています。患者数が増加し、ヘルスケアプロバイダーが効率的な診断ツールを優先していることから、CEDM市場の診断分野は継続的な成長が見込まれています。

予測期間中にCAGRが最も高くなると予想される病院分野

造影デジタルマンモグラフィ（CEDM）市場における病院分野は、近年著しい成長を遂げています。技術の進歩と乳がん早期発見の重要性に対する意識の高まりにより、病院ではCEDMシステムの導入が増加しています。さらに、CEDMを病院環境に組み込むことで、患者は一つ屋根の下で包括的な乳房画像診断サービスを利用できるようになり、このセグメントの成長に寄与しています。乳がん検診の改善を目的とした有利な償還政策や政府の取り組みが、病院におけるCEDMの採用をさらに後押ししています。

最大のシェアを占める地域

予測期間中、乳がんの罹患率の高さと増加により、北米が最大の市場シェアを占めると予測されています。市場成長を促進すると予想される主な要因には、同地域における乳房悪性腫瘍検出のための高度診断技術の採用の増加、従来のMRI技術に対する造影デジタルマンモグラフィ（CEDM）の優位性、乳がん罹患率の上昇、乳がんの早期発見とスクリーニングに対する意識の高まりなどがあります。

CAGRが最も高い地域：

より良い医療施設を提供するために民間機関や政府機関がさまざまな取り組みを行っていることから、アジア太平洋地域が予測期間中に最も高いCAGRを示すと予測されています。造影デジタルマンモグラフィ（CEDM）の低価格化、標準的なMRIと比べた処置時間の短さ、地域における乳がん患者の急増。無料のがん検診を提供する政府プログラムも業界を後押ししています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかを提供いたします：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 技術分析
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の造影デジタルマンモグラフィ（CEDM）市場：画像タイプ別

• 3D画像
• 2D画像

第6章 世界の造影デジタルマンモグラフィ（CEDM）市場：技術別

• 時間的減算
• デュアルエネルギーCEDM
• その他の技術

第7章 世界の造影デジタルマンモグラフィ（CEDM）市場：用途別

• スクリーニング
• 診断
• その他の用途

第8章 世界の造影デジタルマンモグラフィ（CEDM）市場：エンドユーザー別

• 診断センター
• 病院
• 専門クリニック
• その他のエンドユーザー

第9章 世界の造影デジタルマンモグラフィ（CEDM）市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイリング

• Allengers Medical Systems Limited
• Bmi Biomedical International S.R.L.
• Carestream Health
• Gamma Medica, Inc.
• GE Healthcare
• Hologic Inc.
• Konica Minolta, Inc.
• Koninklijke Philips N.V.
• Metaltronica S.p.A
• Planmed Oy
• Siemens Healthcare GmbH
• Toshiba Medical Systems
• Villa Systems Medical SpA

List of Tables

• Table 1 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 3 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 4 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 5 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 6 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 7 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 8 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 9 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 10 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 11 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 12 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 13 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 14 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 15 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 16 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 17 Global Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 18 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Country (2022-2030) ($MN)
• Table 19 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 20 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 21 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 22 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 23 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 24 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 25 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 26 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 27 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 28 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 29 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 30 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 31 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 32 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 33 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 34 North America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 35 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Country (2022-2030) ($MN)
• Table 36 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 37 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 38 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 39 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 40 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 41 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 42 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 43 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 44 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 45 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 46 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 47 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 48 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 49 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 50 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 51 Europe Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 52 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Country (2022-2030) ($MN)
• Table 53 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 54 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 55 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 56 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 57 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 58 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 59 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 60 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 61 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 62 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 63 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 64 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 65 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 66 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 67 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 68 Asia Pacific Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 69 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Country (2022-2030) ($MN)
• Table 70 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 71 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 72 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 73 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 74 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 75 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 76 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 77 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 78 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 79 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 80 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 81 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 82 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 83 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 84 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 85 South America Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 86 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Country (2022-2030) ($MN)
• Table 87 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Image Type (2022-2030) ($MN)
• Table 88 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 3D images (2022-2030) ($MN)
• Table 89 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By 2D images (2022-2030) ($MN)
• Table 90 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Technology (2022-2030) ($MN)
• Table 91 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Temporal Subtraction (2022-2030) ($MN)
• Table 92 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Dual Energy CEDM (2022-2030) ($MN)
• Table 93 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Technologies (2022-2030) ($MN)
• Table 94 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Application (2022-2030) ($MN)
• Table 95 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Screening (2022-2030) ($MN)
• Table 96 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnosis (2022-2030) ($MN)
• Table 97 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 98 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By End User (2022-2030) ($MN)
• Table 99 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Diagnostic Centers (2022-2030) ($MN)
• Table 100 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Hospital (2022-2030) ($MN)
• Table 101 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 102 Middle East & Africa Contrast Enhanced Digital Mammography (CEDM) Market Outlook, By Other End Users (2022-2030) ($MN)

According to Stratistics MRC, the Global Contrast Enhanced Digital Mammography (CEDM) Market is accounted for $462.59 million in 2024 and is expected to reach $952.91 million by 2030 growing at a CAGR of 12.8% during the forecast period. Contrast-Enhanced Digital Mammography (CEDM) is an advanced imaging technique used in breast cancer screening and diagnosis. It involves the injection of a contrast agent into the patient's bloodstream, which highlights abnormal blood vessels in breast lesions. This enhances the visibility of suspicious areas on mammograms, particularly in cases where traditional mammography may be inconclusive. CEDM combines the benefits of digital mammography with contrast-enhanced imaging, offering improved sensitivity for detecting breast cancer, especially in dense breast tissue.

According to the U.S. Breast Cancer Statistics, about 1 in 8 women in the U.S. (about 12.4%) would develop invasive breast cancer over the course of her lifetime. Breast cancer, which makes up around 35% of all occurrences of female cancer in Asia, is the most frequent cancer among women, according to the World Health Organization.

Market Dynamics:

Driver:

Time efficient process

A digital mammography is renowned for its quick results, which are available right away for the doctors to review. There is no requirement to spend time on film developing as there would be in a conventional process. During the examination, the technician can see the results on the computer screen. They can also be altered to magnify and concentrate on specific locations. It is also feasible to alter the contrast to distinguish between normal and diseased breast tissues. As a result, this is the main element fueling the market's expansion.

Restraint:

Reduced spatial resolution

Digital mammography also has a function with a lower spatial resolution. The projected calcification images are elevated above the lowest resolution limit by the digital geometric magnification. The fact that the picture magnification power on the monitor is not a substitute for true geometric magnification with better focus is another problem. As a result, this factor is preventing the market from expanding.

Opportunity:

Advent of new technology

The death rate from breast cancer is projected to decrease as a result of technological developments in CEDM and several government campaigns to raise awareness. In thick breasts, however, the introduction of contrast-enhanced digital mammography enhances cancer diagnosis. The introduction of breast cancer screening programmes worldwide and the rise in breast cancer prevalence have fuelled the market's expansion.

Threat:

High cost

The price of a digital mammography is more than one using traditional film. The procedure's time savings would cover this cost for the improved facilities. However, research falls short of demonstrating the advantages of breast cancer detection. Additionally, there is a lower chance of a contrast allergic reaction and a higher radiation dose compared to traditional mammography. Contrast-enhanced mammography solutions are hindering the market's growth because breast MR is more time-consuming, expensive, and uncomfortable for patients.

Covid-19 Impact:

The market has been adversely affected by the COVID-19 pandemic. Globally, the pandemic led to significant declines in breast cancer screening, cancer management visits, and cancer operations. Due to the lockdown measures in several nations and the delays in manufacturing and production of a wide variety of X-ray imaging devices, including mammography systems, the pandemic epidemic has had an impact on the growth of the business for mammography systems.

The diagnosis segment is expected to be the largest during the forecast period

The diagnosis segment in the Contrast Enhanced Digital Mammography (CEDM) market has witnessed notable growth due to advancements in imaging technology and an increasing emphasis on early detection of breast cancer. CEDM offers enhanced contrast and improved lesion detection capabilities compared to traditional mammography, driving its adoption in diagnostic procedures. Additionally, rising awareness about the importance of early diagnosis and the need for more accurate imaging modalities has spurred demand for CEDM systems. With a growing patient pool and healthcare providers prioritizing efficient diagnostic tools, the diagnosis segment in the CEDM market is poised for continued growth.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospital segment within the Contrast Enhanced Digital Mammography (CEDM) market has witnessed significant growth in recent years. With advancements in technology and increasing awareness about the importance of early detection of breast cancer, hospitals have been increasingly adopting CEDM systems. Additionally, the integration of CEDM into hospital settings provides patients with access to comprehensive breast imaging services under one roof, contributing to the segment's growth. Favourable reimbursement policies and government initiatives aimed at improving breast cancer screening have further propelled the adoption of CEDM in hospitals.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to high prevalence and increase in incidence of breast cancer. Some of the key factors anticipated to propel the market growth include the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region, the superiority of contrast-enhanced digital mammography over the traditional MRI technique, rising incidence of breast cancer, and growing awareness of early detection and screening of breast cancer.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to various initiatives taken by private and government institutions to provide better health care facilities. Low cost of contrast-enhanced digital mammography, quicker procedure time compared to standard MRI, and a sharp increase in the number of breast cancer patients in the area. Government programmes offering free cancer screenings are also propelling the industry.

Key players in the market

Some of the key players in Contrast Enhanced Digital Mammography (CEDM) market include Allengers Medical Systems Limited, Bmi Biomedical International S.R.L., Carestream Health, Gamma Medica, Inc., GE Healthcare, Hologic Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Metaltronica S.p.A, Planmed Oy, Siemens Healthcare GmbH, Toshiba Medical Systems and Villa Systems Medical SpA.

Key Developments:

In May 2024, Konica Minolta, Inc. has been actively working to use recycled plastics, which contribute to a recycling-oriented society. Leveraging its know-how of high-functionality recycling, the Company has started supplying recycled plastics derived from used polycarbonate (PC) water bottles through joint development with NEC Platforms, Ltd. (NEC Platforms) for exterior parts of an Aterm home Wi-Fi router manufactured by NEC Platforms.

In November 2023, Toshiba Medical Systems Europe is launching a new 80-row multislice CT scanner, called Aquilion Prime SP, at next week's U.K. Radiological Congress (UKRC) in Manchester. Aquilion Prime SP includes a number of Toshiba technologies designed to meet increasing demands for superior imaging and outstanding economic performance, according to the company. It includes technologies such as Toshiba's PureVision Optics mode, which makes up to 40% more efficient use of x-rays.

Image Types Covered:

• 3D images
• 2D images

Technologies Covered:

• Temporal Subtraction
• Dual Energy CEDM
• Other Technologies

Applications Covered:

• Screening
• Diagnosis
• Other Applications

End Users Covered:

• Diagnostic Centers
• Hospital
• Specialty Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Contrast Enhanced Digital Mammography (CEDM) Market, By Image Type

• 5.1 Introduction
• 5.2 3D images
• 5.3 2D images

6 Global Contrast Enhanced Digital Mammography (CEDM) Market, By Technology

• 6.1 Introduction
• 6.2 Temporal Subtraction
• 6.3 Dual Energy CEDM
• 6.4 Other Technologies

7 Global Contrast Enhanced Digital Mammography (CEDM) Market, By Application

• 7.1 Introduction
• 7.2 Screening
• 7.3 Diagnosis
• 7.4 Other Applications

8 Global Contrast Enhanced Digital Mammography (CEDM) Market, By End User

• 8.1 Introduction
• 8.2 Diagnostic Centers
• 8.3 Hospital
• 8.4 Specialty Clinics
• 8.5 Other End Users

9 Global Contrast Enhanced Digital Mammography (CEDM) Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Allengers Medical Systems Limited
• 11.2 Bmi Biomedical International S.R.L.
• 11.3 Carestream Health
• 11.4 Gamma Medica, Inc.
• 11.5 GE Healthcare
• 11.6 Hologic Inc.
• 11.7 Konica Minolta, Inc.
• 11.8 Koninklijke Philips N.V.
• 11.9 Metaltronica S.p.A
• 11.10 Planmed Oy
• 11.11 Siemens Healthcare GmbH
• 11.12 Toshiba Medical Systems
• 11.13 Villa Systems Medical SpA